Inactive Instrument

Calendar Interpace Biosciences, Inc. Other OTC

Equities

IDXG

US46062X3035

Chart calendar Interpace Biosciences, Inc.

1d0c6d031bf97a9ac8a5be3c068af5.XW3D_3aFgHUgg3kEjFFUs3dz2XHGMZdDF9mQLO-XmA8.HxmouA7d5hgTtApz5AE6_iUalgaTcP4Kdp_PGJb04nYzPKWaRcHrFhfJLA~e57eb36190e06b3af69333a163e812ee

Upcoming events on Interpace Biosciences, Inc.

2024-05-12 Q1 2024 Earnings Release (Projected)
2024-08-12 Q2 2024 Earnings Release (Projected)
2024-11-11 Q3 2024 Earnings Release (Projected)
2025-03-25 Q4 2024 Earnings Release (Projected)

Past events on Interpace Biosciences, Inc.

2024-03-07 08:00 am Q4 2023 Earnings Release
2023-11-13 Annual General Meeting
2023-11-08 03:29 pm Q3 2023 Earnings Release
2023-08-09 12:30 pm Q2 2023 Earnings Release
2023-03-27 04:05 pm Q4 2022 Earnings Release
2022-11-14 04:41 pm Q3 2022 Earnings Release
2022-11-09 Annual General Meeting
2022-10-19 American Thyroid Association Meeting - Poster #119
2022-08-15 04:05 am Interim 2022 Earnings Release
2022-05-16 04:15 pm Q1 2022 Earnings Release
2022-03-31 04:15 pm FY 2021 Earnings Release
2021-11-10 04:05 pm Q3 2021 Earnings Release
2021-11-07 Annual General Meeting
2021-08-10 04:05 pm Interim 2021 Earnings Release
2021-05-11 04:47 pm Q1 2021 Earnings Release
2021-03-31 05:20 pm FY 2020 Earnings Release
2021-01-21 04:30 pm Q3 2020 Earnings Call
2021-01-21 08:30 am Q3 2020 Earnings Release
2020-10-21 08:30 am Interim 2020 Earnings Call
2020-10-20 08:00 am Interim 2020 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021
Net sales
Million USD
Released
Forecast
Spread
24,1
30,8
-21.8%
32,4
32,3
0.45%
41,3
42,0
-1.54%
EBITDA
Million USD
Released
Forecast
Spread
-17,0
-11,8
-43.72%
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-26,4
-18,9
-40.14%
-26,1
-23,5
-11.02%
-14,0
-12,7
-10.07%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-26,7
-19,6
-35.83%
-26,1
-23,4
-11.65%
-15,4
-13,9
-11.26%
Net income
Million USD
Released
Forecast
Spread
-26,7
-19,8
-35.31%
-29,5
-26,7
-10.46%
-14,9
-13,3
-11.98%
EPS
USD
Released
Forecast
Spread
-7,25
-4,41
-64.59%
-7,32
-6,62
-10.57%
-3,61
-2,61
-38.31%
Announcement Date22/04/2031/03/2131/03/22

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3
Net sales
Million USD
Released
Forecast
Spread
10,9
11,5
-5.63%
10,4
9,00
15.3%
9,35
10,5
-10.94%
8,19
12,5
-34.49%
EBIT
Million USD
Released
Forecast
Spread
-3,28
-2,00
-64.21%
-2,03
-3,25
37.35%
-3,73
-2,09
-78.99%
-0,78
-0,93
15.68%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-3,69
-2,13
-73.24%
-2,18
-3,38
35.65%
-3,87
-2,22
-74.37%
-1,27
-1,06
-19.34%
Net income
Million USD
Released
Forecast
Spread
-3,73
-2,13
-75.07%
-2,25
-3,38
33.52%
-3,94
-2,22
-77.43%
-14,2
-1,06
-1240.38%
EPS
USD
Released
Forecast
Spread
-0,89
-0,26
-242.31%
-0,53
-0,80
33.75%
-0,93
-0,52
-78.85%
-3,35
-0,25
-1240%
Announcement Date31/03/2216/05/2215/08/2214/11/22
  1. Stock Market
  2. Equities
  3. IDXG Stock
  4. IDXG Stock
  5. Calendar Interpace Biosciences, Inc.